http://www.medcitynews.com/2010/02/wisconsin-angel-credits-could-snag-top-minnesota-biotech-start-up/?utm_source=rss&utm_medium=rss&utm_campaign=wisconsin-angel-credits-could-snag-top-minnesota-biotech-start-up MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2010/02/wisconsin-angel-credits-could-snag-top-minnesota-biotech-start-up/comment-page-1/#comment-60079 Miromatrix and University of Minnesota ink licensing deal : MedCity News Tue, 16 Feb 2010 19:45:14 +0000 http://www.medcitynews.com/?p=19993#comment-60079 [...] The company is also close to securing a state aid package, which might include loans and tax breaks, that will allow Miromatrix to remain in Minnesota. Negotiations are at “a sensitive stage” and could still fall apart, said CEO Robert Cohen, noting the company has attracted interest from several states, including Wisconsin. [...] [...] The company is also close to securing a state aid package, which might include loans and tax breaks, that will allow Miromatrix to remain in Minnesota. Negotiations are at “a sensitive stage” and could still fall apart, said CEO Robert Cohen, noting the company has attracted interest from several states, including Wisconsin. [...]

]]> http://www.medcitynews.com/2010/02/wisconsin-angel-credits-could-snag-top-minnesota-biotech-start-up/comment-page-1/#comment-58812 Weekend Rounds: Contract drug developer Ricerca gets bigger; Boston Scientific heart businesses get smaller : MedCity News Sat, 13 Feb 2010 19:00:23 +0000 http://www.medcitynews.com/?p=19993#comment-58812 [...]      ♦   Dr. Doris Taylor, the University of Minnesota cell biologist who grew a rat’s heart in a jar and founder of Miromatrix Inc., one of the state’s most promising biotech start-ups trying to commercialize her research, said passing the proposed angel investment tax credit “is the difference between [Minnesota] operating in the 19th century or the 21st century.” As long as neighboring Wisconsin continues to boost its angel credits and Minnesota dithers on passing any tax credits, Minnesota start-ups could continue to flock across the border. [...] [...]      ♦   Dr. Doris Taylor, the University of Minnesota cell biologist who grew a rat’s heart in a jar and founder of Miromatrix Inc., one of the state’s most promising biotech start-ups trying to commercialize her research, said passing the proposed angel investment tax credit “is the difference between [Minnesota] operating in the 19th century or the 21st century.” As long as neighboring Wisconsin continues to boost its angel credits and Minnesota dithers on passing any tax credits, Minnesota start-ups could continue to flock across the border. [...]

]]>